...
首页> 外文期刊>International Journal of Pharmaceutical and Life Sciences >Nanosuspension: A Novel Drug Delivery System
【24h】

Nanosuspension: A Novel Drug Delivery System

机译:纳米悬浮液:一种新型的药物输送系统

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Low bioavailability is the major problem associated with poorly soluble drugs. The problem is more complex for drugs which are poorly soluble in both aqueous and nonaqueous media, as solubility is an essential factor for drug absorption, independent of the route of administration. Nanosuspensions have emerged as an attractive and promising approach to improve stability and bioavailability of poorly soluble drugs. These are very finely colloid, biphasic, dispersed, solid drug particles in an aqueous vehicle, size below 1μm, without any matrix material, stabilized by surfactants and polymers. Techniques such as wet milling, high-pressure homogenization, emulsification-solvent evaporation and supercritical fluid have been used in the preparation of nanosuspension. Nanosuspension can be delivered by oral, parenteral, pulmonary and ocular routes. DOI: http://dx.doi.org/10.3329/ijpls.v2i4.17117 International Journal of Pharmaceutical and Life Sciences Volume 2, Issue 4: October 2013; 179-196
机译:生物利用度低是与难溶性药物有关的主要问题。对于难溶于水和非水介质的药物,问题更为复杂,因为溶解度是药物吸收的必要因素,与给药途径无关。纳米悬浮液已经成为改善难溶性药物的稳定性和生物利用度的一种有吸引力且有希望的方法。这些是在水性介质中的非常细的胶体,两相,分散的固体药物颗粒,尺寸小于1μm,没有任何基质材料,由表面活性剂和聚合物稳定。湿磨,高压均质,乳化-溶剂蒸发和超临界流体等技术已用于制备纳米悬浮液。纳米混悬剂可以通过口服,肠胃外,肺和眼途径递送。 DOI:http://dx.doi.org/10.3329/ijpls.v2i4.17117国际药学与生命科学杂志第2卷,第4期:2013年10月; 179-196

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号